Philanthropy in Medical Research 生物医学研究慈善家
March 13, 2021
by Larry Zhang
Having experienced the devastating effects of polymyositis, an autoimmune disease, and pulmonary fibrosis, Huayi became a dedicated advocate of medical research and clinical treatments, determined to help others touched by similar diseases.
化一在经历了多发性肌炎(一种自身免疫系统和肺纤维化疾病)的病痛中决定大力支持对这种疾病机理和治疗方法的研究,以便帮助更多的患者解除病痛。
In 2011, he established the Zhang Family Endowed Chair in Microbiology and Immunology at Stony Brook University and in 2017, an endowed chair in Rheumatology. These endowed chairs have helped, and continue to help Stony Brook University recruit and retain world-class researchers in the fields of immunology, virology, and infectious diseases.
2011年,化一在纽约石溪大学建立了张氏微生物学和免疫学冠名教授职位,2017年又在该大学建立了风湿学冠名教授职位。这些捐赠持续帮助纽约石溪大学招聘和拥有在免疫学,病毒学,传染病学,及风湿病学领域世界级水平的研究学者。
In 2012, he and his wife established the “Huayi and Siuling Discovery Fund” at Johns Hopkins University Myositis Center. This funded the research of chief investigators Dr. Lisa Christopher-Stine and Dr. Sonye Danoff to better understand and treat this rare disease. They have published numerous results since the fund was established.
在2012年,化一和夫人在约翰.霍普金斯大学的肌炎研究中心设立了‘化一和秀玲探索基金’用来支持该中心的首席研究员克里斯托弗.斯汀博士和索尼.丹诺夫博士对罕见肌炎的深入研究和治疗。自从基金的建立至今,研究发现和成果已经在多家医学论文杂志上发表。
Huayi was also a lifetime advocate of traditional Chinese Medicine. Since 2006, he and Siuling have provided funding for world-class Chinese Medicine lecturers to teach at New York College of Traditional Chinese Medicine. In 2011, a research project called PROLUNG was initiated by them to study the effectiveness of Chinese herbal medicine to treat pulmonary fibrosis. A clinical trial was conducted at the University of Hong Kong’s School of Chinese Medicine from August 2018 to May 2020. The draft of the clinical trial result was written on February 10th, 2021 and is awaiting publication.
化一还长期提倡传统中医。自2006年以来,他和夫人提供了资金资助世界级中医大师们到纽约中医药学院授课。2011年他们发起和支持了‘PROLUNG’研究项目旨在探讨用中药治疗肺纤维化的效果。香港大学中医学院已经在2018年8月至2020年5月进行了临床试验。试验结果已在2021年2月10日写成论文即将发表。
化一在经历了多发性肌炎(一种自身免疫系统和肺纤维化疾病)的病痛中决定大力支持对这种疾病机理和治疗方法的研究,以便帮助更多的患者解除病痛。
In 2011, he established the Zhang Family Endowed Chair in Microbiology and Immunology at Stony Brook University and in 2017, an endowed chair in Rheumatology. These endowed chairs have helped, and continue to help Stony Brook University recruit and retain world-class researchers in the fields of immunology, virology, and infectious diseases.
2011年,化一在纽约石溪大学建立了张氏微生物学和免疫学冠名教授职位,2017年又在该大学建立了风湿学冠名教授职位。这些捐赠持续帮助纽约石溪大学招聘和拥有在免疫学,病毒学,传染病学,及风湿病学领域世界级水平的研究学者。
In 2012, he and his wife established the “Huayi and Siuling Discovery Fund” at Johns Hopkins University Myositis Center. This funded the research of chief investigators Dr. Lisa Christopher-Stine and Dr. Sonye Danoff to better understand and treat this rare disease. They have published numerous results since the fund was established.
在2012年,化一和夫人在约翰.霍普金斯大学的肌炎研究中心设立了‘化一和秀玲探索基金’用来支持该中心的首席研究员克里斯托弗.斯汀博士和索尼.丹诺夫博士对罕见肌炎的深入研究和治疗。自从基金的建立至今,研究发现和成果已经在多家医学论文杂志上发表。
Huayi was also a lifetime advocate of traditional Chinese Medicine. Since 2006, he and Siuling have provided funding for world-class Chinese Medicine lecturers to teach at New York College of Traditional Chinese Medicine. In 2011, a research project called PROLUNG was initiated by them to study the effectiveness of Chinese herbal medicine to treat pulmonary fibrosis. A clinical trial was conducted at the University of Hong Kong’s School of Chinese Medicine from August 2018 to May 2020. The draft of the clinical trial result was written on February 10th, 2021 and is awaiting publication.
化一还长期提倡传统中医。自2006年以来,他和夫人提供了资金资助世界级中医大师们到纽约中医药学院授课。2011年他们发起和支持了‘PROLUNG’研究项目旨在探讨用中药治疗肺纤维化的效果。香港大学中医学院已经在2018年8月至2020年5月进行了临床试验。试验结果已在2021年2月10日写成论文即将发表。